Publikationen von Jonathan J. Swietlik

Swietlik, J. J.; Barthel, S.; Falcomata, C.; Fink, D.; Sinha, A.; Cheng, J.; Ebner, S.; Landgraf, P.; Dieterich, D. C.; Daub, H. et al.; Saur, D.; Meissner, F.: Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation. Nature Communications 14 (1), 2642 (2023)

Falcomata, C.; Baerthel, S.; Widholz, S. A.; Schneeweis, C.; Montero, J. J.; Toska, A.; Mir, J.; Kaltenbacher, T.; Heetmeyer, J.; Swietlik, J. J. et al.; Cheng, J.-Y.; Teodorescu, B.; Reichert, O.; Schmitt, C.; Grabichler, K.; Coluccio, A.; Boniolo, F.; Veltkamp, C.; Zukowska, M.; Vargas, A. A.; Paik, W. H.; Jesinghaus, M.; Steiger, K.; Maresch, R.; Oellinger, R.; Ammon, T.; Baranov, O.; Robles, M. S.; Rechenberger, J.; Kuster, B.; Meissner, F.; Reichert, M.; Flossdorf, M.; Rad, R.; Schmidt-Supprian, M.; Schneider, G.; Saur, D.: Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Nature Cancer 3, S. 318 - 336 (2022)

Phulphagar, K.; Kuehn, L. I.; Ebner, S.; Frauenstein, A.; Swietlik, J. J.; Rieckmann, J.; Meissner, F.: Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis. Cell Reports 34 (10), 108826 (2021)

Swietlik, J. J.; Sinha, A.; Meissner, F.: Dissecting intercellular signaling with mass spectrometry-based proteomics. CURRENT OPINION IN CELL BIOLOGY 63, S. 20 - 30 (2020)

Swietlik, J.: Development and Application of Mass Spectrometry-Based Proteomic Approaches for Investigating Intercellular Signalling. Dissertation, Ludwig-Maximilians-Universität München, Fakultät für Chemie und Pharmazie, München (2025)